Evangeline Lilly, who has been navigating a traumatic brain injury following a concussion, opened up about her recovery ...

Both companies may succeed in this industry.

Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA ...

Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.

Seamless will receive over $1.1 billion, which also includes potential milestone payments for achieving development and ...

BERLIN, Jan 27 (Reuters) - Roche's experimental obesity drug, which works in a similar way to Eli Lilly's Zepbound, produced ...

GLP-1 giant Eli Lilly has once again taken to the medium of short film to deliver an important message about obesity. | GLP-1 ...

The agreement with Seamless is the latest in a series of purchases and partnerships Lilly has established to build a pipeline ...

The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...

Lilly inks gene therapy deal with Seamless Therapeutics to develop programmable recombinase treatments targeting genetic hearing loss worldwide.

This biotech has candidates in late-stage clinical development.